A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/59 (2006.01) A61K 31/593 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2292734
A method of moderating transplant rejection in a transplant recipient comprising administering a dose of vitamin D compound effective to prevent transplant rejection is disclosed. Preferably, the recipient's susceptibility to opportunistic infections has not been compromised. Also preferably, the recipient has not suffered bone demineralization.
La présente invention se rapporte à un procédé permettant de réduire les risques de rejet de greffe chez un receveur, qui comprend l'administration d'une dose d'un composé de vitamine D utile pour empêcher le rejet de la greffe. De préférence, la réceptivité du receveur aux infections opportunistes n'a pas été affaiblie et le sujet n'a pas subi de déminéralisation osseuse.
Cantorna Margherita T.
Deluca Hector F.
Hayes Collen E.
Hullett Debra A.
Humpal-Winter Jean
Borden Ladner Gervais Llp
Wisconsin Alumni Research Foundation
LandOfFree
Use of vitamin d compounds to prevent transplant rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of vitamin d compounds to prevent transplant rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of vitamin d compounds to prevent transplant rejection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2055324